Desmethylimipramine attenuates cocaine withdrawal in rats (original) (raw)

• American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Association, Washington DC
  Google Scholar
• Asakura M, Tsukamoto T, Kubota H, Imafuku J, Ino M, Nishizaki J, Sato A, Shinbo K, Hasegawa K (1987) Role of serotonin in the regulation of beta-adrenoreceptors by antidepressants. Eur J Pharmacol 141:95–100
  Article PubMed Google Scholar
• Aulakh CS, Cohen RM, Pradhan SN, Murphy DL (1985) Long-term desipramine treatment attenuates clonidine-induced suppression of ventral tegmental self-stimulation. Life Sci 36:443–447
  Article PubMed Google Scholar
• Baxter LR (1983) Desipramine in the treatment of hypersomnolence following abrupt cessation of cocaine use. Am J Psychiatry 140:1525–1526
  PubMed Google Scholar
• Binks SM, Murchie JK, Greenwood DT (1979) A reward-reduction model of depression using self stimulating rats: an appraisal. Pharmacol Biochem Behav 10:441–443
  Article PubMed Google Scholar
• Brunello N, Barbaccia ML, Chuang D, Costa E (1982) Down-regulation of beta-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonin axons. Neuropharmacology 21:1145–1149
  Article PubMed Google Scholar
• Cohen J, Cohen, P (1975) Applied multiple regression/correlation analysis for the behavioral sciences. Lawrence Erlbaum, Hillsdale NJ
  Google Scholar
• DeMontis GM, Devoto P, Gessa GL, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A (1990) Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur J Pharmacol 180:31–35
  Article PubMed Google Scholar
• Dixon WJ (1988) BMDP biomedical computer programs. California Press, University of Los Angeles, California Press
• Dworkin SI, Goeders NE, Grabowski J, Smith JE (1987) The effects of 12-hour limited access to cocaine: reduction in drug intake and mortality. NIDA Res Monogr 76:221–225
  PubMed Google Scholar
• Ellinwood EH, Petrie WM (1977) Dependence on amphetamine, cocaine and other stimulants. In: SN Pradhan (ed) Drug abuse: clinical and basic aspects. CV Mosby, St Louis, pp 248–262
  Google Scholar
• Fechner GT (1966; original work published in 1860) In: Adler HE, Howes DH, Boring EG (eds and translators) Elements of psychophysics, vol 1. Holt, Rinehart & Winston, New York
  Google Scholar
• Fibiger HC, Phillips AG (1981) Increased intracranial self-stimulation in rats after long-term administration of desipramine. Science 214:683–685
  PubMed Google Scholar
• Fischman MW, Foltin RW, Nestadt G, Pearlson GD (1990) Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 253:760–770
  PubMed Google Scholar
• Flicker C, Geyer MA (1982) Behavior during hippocampal microinfusions: I. Norepinephrine and diversive exploration. Brain Res Rev 4:79–103
  Article Google Scholar
• Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63:844–914
  PubMed Google Scholar
• Frank RA, Pommering T, Nitz D (1988) The interactive effects of cocaine and imipramine on self-stimulation train-duration thresholds. Pharmacol Biochem Behav 30 [1]:1–4
  Article PubMed Google Scholar
• Gallistel CR (1973) Self-stimulation: the neurophysiology of reward and motivation: In: Deutsch JA (ed) The physiological basis of memory. Academic Press, New York, pp 210–267
  Google Scholar
• Gawin FH (1986) New uses of antidepressants in cocaine abuse. Psychosomatics 27:S24-S29
  Google Scholar
• Gawin FH (1991) Cocaine addiction: psychology and neurophysiology. Science 251:1580–1586
  PubMed Google Scholar
• Gawin FH, Kleber H (1984) Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry 41:903–909
  PubMed Google Scholar
• Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107–113
  PubMed Google Scholar
• Gawin FH, Kleber HD (1988) Evolving conceptualizations of cocaine dependence. Yale J Biol Med 61:123–136
  PubMed Google Scholar
• Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C (1989) Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 46:117–121
  PubMed Google Scholar
• Geisser S, Greenhouse S (1959) On methods in the analysis of profile data. Psychometrica 24:95–112
  Google Scholar
• Giannini AJ, Billett W (1987) Bromocriptine-desipramine protocol in treatment of cocaine addiction. J Clin Pharmacol 27:549–554
  PubMed Google Scholar
• Giannini AJ, Malone DA (1986) Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine. J Clin Pharmacol 26:211–224
  PubMed Google Scholar
• Giannini AJ, Folts DJ, Feather JN, Sullivan BS (1989) Bromocriptine and amantadine in cocaine detoxification. Brain Res 29:11–16
  Google Scholar
• Glick SD, Weaver LM, Meibach RC (1980) Lateralization of reward in rats: differences in reinforcing thresholds. Science 207:1093–1095
  PubMed Google Scholar
• Glick SD, Weaver LM, Meibach RC (1981) Amphetamine enhancement of reward asymmetry. Psychopharmacology 73:323–327
  Article PubMed Google Scholar
• Green AR (1987) Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters. Neuropharmacology 26:815–822
  Article PubMed Google Scholar
• Hall FS, Stellar JR, Kelley AE (1990) Acute and chronic desipramine treatment effects on rewarding electrical stimulation of the lateral hypothalamus. Pharmacol Biochem Behav 37:277–281
  Article PubMed Google Scholar
• Hauger RL, Irwin MR, Dupont RM, Papolos DF (1991) Treatment-resistant bipolar affective disorder: phenomenological characteristics, pathophysiological mechanisms, and novel therapies. In: Amsterdam JD (ed) Advances in neuropsychiatry and psychopharmacology. Raven Press, New York, pp 131–154
  Google Scholar
• Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet ii:632
  Article Google Scholar
• Kleven MS, Woolverton WL (1990) Effects of bromocriptine and desipramine on behavior maintained by cocaine or food presentation in rhesus monkeys. Psychopharmacology 101:208–213
  Google Scholar
• Kokkinidis L, McCarter BD (1990) Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects. Pharmacol Biochem Behav 36:463–471
  Article PubMed Google Scholar
• Kokkinidis L, Zacharko RM, Predy PA (1980) Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants. Pharmacol Biochem Behav 13:379–383
  Article PubMed Google Scholar
• Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715–723
  PubMed Google Scholar
• Kornetsky C, Esposito RU (1979) Euphorigenic drugs: effects on reward pathways of the brain. Fed Proc 38:2473–2476
  PubMed Google Scholar
• Leichtling BH, Su YF, Wimalasena J, Harden TK, Wolfe BB, Wicks WD (1978) Studies of cAMP metabolism in cultured hepatoma cells: presence of functional adenylate cyclase despite low cAMP content and lack of hormonal responsiveness. J Cell Physiol 96:215–224
  Article PubMed Google Scholar
• Liebman JM (1983) Discriminating between reward and performance: a critical review of intracranial self-stimulation methodology. Neurosci Biobehav Rev 7:45–72
  Article PubMed Google Scholar
• Liebman JM, Cooper SJ (1989) The neuropharmacological basis of reward. Clarendon Press, Oxford.
  Google Scholar
• Maj J, Papp M, Skuza G, Bigajska K, Zazula M (1989) The influence of repeated treatment with imipramine, (+)- and (−)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists. J Neural Transm 76:29–38
  Article PubMed Google Scholar
• Manier DH, Gillespie DD, Steranka LR, Sulser F (1984) A pivotal role of serotonin (5HT) in the regulation of beta adrenoreceptors by antidepressants: reversibility of the action of parachlorophenylalanine by 5-hydroxytroptophan. Experentia 40:1223–1226
  Article Google Scholar
• Manier DH, Gillespie DD, Sanders-Bush E, Sulser F (1987) The serotonin/noradrenaline-link in brain. Naunyn-Schmiedeberg's Arch Pharmacol 335:109–114
  Google Scholar
• Markou A, Frank RA (1987) The effect of operant and electrode placement on self-stimulation train duration response functions. Physiol Behav 41:303–308
  PubMed Google Scholar
• Markou A, Koob GF (1991) Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology 4:17–26
  PubMed Google Scholar
• Markou A, Koob GF (1992a) Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav 51 [1]:111–119
  PubMed Google Scholar
• Markou A, Koob GF (1992b) Bromocriptine reverses post-cocaine anhedonia in a rat model of cocaine withdrawal. Neuropsychopharmacology (in press)
• Martin-Iverson MT, Leclere J-F, Fibiger HC (1983) Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants. Eur J Pharmacol 94:193–201
  Article PubMed Google Scholar
• McCarter BD, Kokkinidis L (1989) The effects of long-term administration of antidepressant drugs on intracranial self-stimulation responding in rats. Pharmacol Biochem Behav 31:243–247
  Article Google Scholar
• Munson PJ, Rodbard D (1980) LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220–239
  Article PubMed Google Scholar
• Muscat R, Sampson D, Willner P (1990) Dopaminergic mechanism of imipramine action in an animal model of depression. Biol Psychiatry 28:223–230
  Article PubMed Google Scholar
• O'Donnell JM, Wolfe, BB, Frazer, A (1984) Agonist interactions with beta adrenergic receptors in the rat brain. J Pharmacol Exp Ther 228:640–647
  PubMed Google Scholar
• Olds ME, Fobes JL (1981) The central basis of motivation: intracranial self-stimulation studies. Annu Rev Psychol 32:523–574
  Article PubMed Google Scholar
• Pedhazur EJ (1982) Multiple regression in behavioral research, 2nd edn. Holt, Rinehart and Winston, New York
  Google Scholar
• Potter WZ, Rudorfer MV, Linnoila, M (1988) New clinical studies support a role of norepinephrine antidepressant action. In: Perspectives in psychopharmacology. Liss, New York, pp 495–513
  Google Scholar
• Resnick R, Schuyten-Resnick E. (1977) Clinical aspects of cocaine: assessment of cocaine abuse behavior in man. In: Mule SJ (ed) Cocaine. CRC Press, Boca Raton, Florida
  Google Scholar
• Risch SC, Cohen RM, Janowsky DS, Kalin NH, Murphy DL (1980) Mood and behavioral effects of physostigmine on humans are accompanied by elevation in plasma beta-endorphin and cortisol. Science 209:1545
  PubMed Google Scholar
• Riva MA, Creese I (1989a) Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [H]dihydroalprenolol. Mol Pharmacol 36:201–210
  PubMed Google Scholar
• Riva MA, Creese I (1989b) Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment. Mol Pharmacol 36:211–218
  PubMed Google Scholar
• Roberts DCS, Koob GF (1982) Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav 17:901–904
  Article PubMed Google Scholar
• Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522
  PubMed Google Scholar
• Sethy VH, Day JS, Cooper MM (1988) Dose-dependent down-regulation of beta-adrenergic receptors after chronic intravenous infusion of antidepressants. Prog Neuropsychopharmacol 12:673–682
  Article Google Scholar
• Simpson DM, Annau Z (1977) Behavioral withdrawal following several psychoactive drugs. Pharmacol Biochem Behav 7:59–64
  Article PubMed Google Scholar
• Spyraki C, Fibiger HC (1981) Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur J Pharmacol 74:195–206
  Article PubMed Google Scholar
• Stellar JR, Rice M (1989) Pharmacological basis of intracranial self-stimulation reward. In: Liebman JF, Cooper SJ (eds) The neuropharmacological basis of reward. Clarendon Press, Oxford, pp 14–65
  Google Scholar
• Stellar JR, Stellar E (1985) The neurobiology of reward and motivation. Springer Berlin Heidelberg, New York
  Google Scholar
• Stiles GL, Caron MG, Lefkowitz RJ (1984)_β_-Adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev 64:661–743
  PubMed Google Scholar
• Tang M, Falk JL (1990) Schedule-induced oral self-administration of cocaine and ethanol solutions: lack of effect of chronic desipramine. Drug Alcohol Depend 25:21–25
  Article PubMed Google Scholar
• Vetulani J, Stawarz RJ, Dingell JV, Sulser F (1976) A possible common mechanism of action of antidepressant treatments. Naunyn-Schmiedeberg's Arch Pharmacol 293:109–114
  Article Google Scholar
• Wilkinson L (1986) SYSTAT: The system for statistics. SYSTAT Evanston, IL
  Google Scholar
• Willner P (1984) The validity of animal models of depression. Psychopharmacology 83:1–16
  Google Scholar
• Willner P, Muscat R, Papp M, Sampson D (1991) Dopamine, depression and antidepressant drugs. In: Willner P, Scheel-Kruger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, Chichester, pp 387–410
  Google Scholar
• Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York
  Google Scholar
• Wolfe BB, Harden TK (1981) Guanine nucleotides modulate the affinity of antagonists at_β_-adrenergic receptors. J Cyclic Nucl Res 7:303–312
  Google Scholar
• Wolfe BB, Harden TK, Sporn JR, Molinoff PB (1978) Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther 207:446–457
  PubMed Google Scholar